Navigation Links
Valeant Launches Senior Notes Offering
Date:3/1/2011

MISSISSAUGA, Ontario, March 1, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (the "Company") announced today that Valeant Pharmaceuticals International ("Valeant"), its wholly owned indirect subsidiary, launched its offer of approximately $1.5 billion aggregate principal amount of senior unsecured notes (the "Notes").

The Notes will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act and applicable state securities laws. The Notes will be offered in the United States only to qualified institutional buyers under Rule 144A of the Securities Act and outside the United States under Regulation S of the Securities Act. The Notes have not been and will not be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the securities in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws.

Valeant intends to use the net proceeds from the offering of the Notes to prepay the amounts outstanding under its term loan A facility (and cancel the undrawn senior secured revolving credit facility); to fund the $275 million repurchase of shares of the Company's common shares from ValueAct Capital Master Fund, L.P. pursuant to the terms of a recently announced privately negotiated purchase and sale agreement; to finance the redemption of Valeant's 4.0% convertible subordinated notes due 2013, which the Company anticipates commencing during the second quarter of 2011; and for general corporate purposes.

This press release shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitati
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals to Present at RBC Capital Markets 2011 Healthcare Conference
2. Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011
3. Valeant Pharmaceuticals Announces License Of ACZONE® (dapsone) Gel 5% In Canada
4. Valeant Launches Senior Notes Offering
5. Valeant Pharmaceuticals to Acquire PharmaSwiss S.A.
6. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
7. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
8. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
9. Valeant Announces Pricing of Senior Notes
10. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
11. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... revenues for the fourth quarter of 2013 will be ... approximately $208 million. "Our full-year revenue growth ...
(Date:1/14/2014)... HARRISBURG, Pa. , Jan. 14, 2014 Dynamic Healthcare ... ("GMH"), announced today that it acquired Progressive Home Medical Equipment, ... January 7, 2014. The terms of the acquisition were not ... medical equipment ("DME") company providing a wide range of sleep, ...
(Date:1/14/2014)... 2014 NineSigma , Inc., the leading innovation ... Leadership Summit , May 14-16, 2014 at the Global ... . This is the premier ... breakthrough achievements through open innovation. Participants will learn how ...
Breaking Medicine Technology:HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... letter is being released by CEL-SCI Corporation (NYSE Alternext ... Shareholders: , I am writing today to provide you with ... on our plans for dealing with the current financial downturn. ... year of meaningful accomplishments which put CEL-SCI in a valuable ...
... Md., Feb. 19 Hospital associations in 10 ... program to test methods of reducing central-line associated ... (ICUs), according to HHS, Agency for Healthcare Research ... Nebraska, North Carolina, Ohio, Pennsylvania, Texas, and Washington. ...
Cached Medicine Technology:CEL-SCI Corporation Releases Letter to Shareholders 2CEL-SCI Corporation Releases Letter to Shareholders 3CEL-SCI Corporation Releases Letter to Shareholders 4CEL-SCI Corporation Releases Letter to Shareholders 510-State Project to Study Methods to Reduce Central Line-Associated Bloodstream Infections in Hospital ICUs 210-State Project to Study Methods to Reduce Central Line-Associated Bloodstream Infections in Hospital ICUs 3
(Date:4/18/2014)... prepped to enter the battle against infectious disease. ... in remote areas, thanks in part to knowledge ... International Space Station on the behavior of liquids. ... flow to diagnose infectious diseases such as HIV/AIDS ... at Northwestern University in Evanston, Ill., had been ...
(Date:4/18/2014)... of Medicine researchers have been awarded two-year grants for ... announced this month. Of the 110 initial submissions to ... Forum Program, only four projects were funded, three of ... Jonathan Powell, M.D., Ph.D.; G. William Wong, Ph.D.; and ... professor of oncology, will use his $500,000 proof of ...
(Date:4/18/2014)... University psychologists have made a brain-related discovery that ... disorders. , This discovery opens up the possibility ... suppress a specific brain activity that the researchers ... The Journal of Neuroscience has just ... McDonald, an associate professor of psychology and his ...
(Date:4/18/2014)... Northwestern Medicine scientists could lead to potential new treatments ... with scleroderma. , Fibrosis, or scarring, is a ... skin and lungs can lead to serious organ damage ... new therapeutic options centers on findings made by Swati ... the role that a specific protein plays in promoting ...
(Date:4/17/2014)... identified the first genetic variant specifically associated with ... for around 10-15 per cent of all breast ... the breast cancer sub-type, called invasive lobular carcinoma, ... of this particular kind of breast cancer, which ... published today (Thursday) in the journal PloS ...
Breaking Medicine News(10 mins):Health News:Space-tested fluid flow concept advances infectious disease diagnoses 2Health News:Space-tested fluid flow concept advances infectious disease diagnoses 3Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3
... America, Inc.,(OTC Bulletin Board: CBAI), the umbilical cord ... on bringing the life,saving potential of stem cells ... for the first quarter of 2008, ended March ... umbilical cord,blood storage business increased 10 percent while ...
... 20 Accelerate Brain Cancer,Cure ( http://www.abc2.org ) ... brain cancer specialists covering important updates on,advancements in ... for newly,diagnosed brain cancer patients., The videos ... the worlds,leading researchers in the fields of brain ...
... May 20 Mayo Clinic researchers,found that the ... is approximately the same at a,multidisciplinary medical center ... rate for 211 hospitals in the National Healthcare ... because it suggests that,care levels are generally strong ...
... Data presented today at the International Conference ... that Perforomist™ Inhalation Solution (formoterol fumarate inhalation ... profile that is comparable to the dry ... Foradil® Aerolizer® 12 g (FA). , ...
... The Board of,Directors of BD (Becton, Dickinson and Company) ... 28.5 cents per common share. The dividend will be,payable ... June 9, 2008. The,indicated annual dividend rate is $1.14 ... global medical technology company that manufactures and,sells medical devices, ...
... the following statement today following reports on Senator Ted,Kennedy,s ... been met with great concern., "Senator Kennedy is ... a,great fighter for America,s children, workers and seniors., ... well in this,challenge., "Our thoughts and prayers are ...
Cached Medicine News:Health News:Cord Blood America Reports First Quarter Financial Results; Gross Profits Increase 2Health News:Brain Cancer Science and Treatment Information 2Health News:Mayo Clinic Research Shows U.S. Intensive Care Units' Prevention of Pneumonia in Critically-ill Patients Generally Strong; Identifies Area of Improvement 2Health News:Mayo Clinic Research Shows U.S. Intensive Care Units' Prevention of Pneumonia in Critically-ill Patients Generally Strong; Identifies Area of Improvement 3Health News:Perforomist-comparable pharmacokinetic and pharmacodynamic profile to DPI formulation 2
... system is an automated solution that identifies the patient, tying all critical information to the patient's unique bar-coded ... ... ... ...
The Metrologic MS9520 Voyager is a high performance single line laser bar code scanner with automatic activation and sophisticated data transmission via Metrologic proprietary CodeGate technology....
... direct thermal wristband ideal for positive ... admissions. Its clip closures provide a ... white for color coding. Designed specifically ... peak performance. Print high-quality text and ...
... The DataMate Laser ... System consists of laser-printable ... closure wristband and laser ... paperwork. The wristbands clear, ...
Medicine Products: